According to the current analysis of Reports and Data, the global Electrophysiology Devices market was valued at USD 6,738.2 Million in 2020 and is expected to reach USD 13.21 Billion by the year 2028, at a CAGR of 8.70%. Electrophysiology (EP) is immensely popular due to its efficacy in terms of controlling and treating arrhythmia. Arrhythmia continues to be one of the significant cardiac disorders, preceded by sudden cardiac death (SCD), accounting for approximately 15-20% of total deaths. Electrophysiology devices are forcing their way through entrenched preferences for conventional methods to treat cardiac arrhythmia. According to WHO, cardiovascular diseases caused 17.5 million deaths globally in 2012. It became the leading cause of non -communicable disease (NCD) deaths. Electrophysiology devices are cardiology specialty devices used primarily in the diagnosis and treatment of cardiac arrhythmias. Thus, the growing prevalence of cardiovascular diseases is expected to boost Electrophysiology Devices market growth. The rising number of sudden cardiac arrest cases is a big threat to the American population. Rising use of defibrillators has proved helpful to reduce the death rates among patients suffering from cardiac arrest outside hospitals.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2277
Introduction of new technologies such as Cryoablation, laser ablation, and ultrasound ablation and advanced mapping technologies are also likely to boost the demand for the Electrophysiology Devices market. Increasing accessibility to healthcare facilities, rising medical tourism, and the increasing incidences of heart failure cases are expected to augment market demand in emerging economies. But, high costs associated with Electrophysiology Devices, presence of strict regulations, and availability of alternative therapies are restraining market growth.
The pharma and healthcare industry is expected to observe significant growth over the coming years attributed to the increasing incidence of chronic diseases across the globe, growing geriatric patient pool, availability of advanced and minimally invasive surgical and diagnostics procedures, favorable reimbursement scenario, and presence of a robust product pipeline of drugs and therapeutics. In addition, the growing integration of IoT, ML, and AI in medical procedures and equipment along with rapid progress in drug design and development. A combination of innovation and technology has brought about massive changes in the healthcare industry and the rapid adoption of telemedicine, remote consultation, and e-prescription has significantly contributed to the revenue growth of the market.
Further key findings from the report suggest:
- The cryoablation segment is anticipated to grow at a CAGR of xx % during the forecast period
- Electrophysiology (EP) technology has been advancing rapidly with new ablation tools to improve atrial fibrillation (AF) treatments, miniaturized diagnostic monitoring systems, and new implantable rhythm management devices that are making procedures much less invasive. Leadless Pacemakers, Wireless CRT, subcutaneous ICDs, new electro mapping systems, ultrasound guidance in Electrophysiology labs
- The radiofrequency and cryoablation are the most widely used Electrophysiology ablation catheters
- Asia-Pacific is a densely-populated region, with India and China being the most populated countries. Emerging economies, such as India and China, provide attractive growth opportunities for electrophysiological device manufacturers. The growth is augmented by the surge in demand for advanced electrophysiology devices, an improvement of healthcare reforms, high prevalence of cardiac arrhythmias, and increased focus of key players for developing technologically advanced cost-effective electrophysiology devices in this region. However, the unfavorable reimbursement scenario for electrophysiology devices, low awareness among physicians and patients about different electrophysiology devices, and high cost of these devices are likely to impede the electrophysiology devices market growth in these countries. In Japan, the atrial fibrillation rate among geriatric population is 2-3%. With the rise in ageing population, it is estimated that atrial fibrillation will affect about one million people by 2050, thereby driving the electrophysiology devices market growth.
- Advances in the electrophysiology (EP) devices landscape has paced up in recent years. One such trend in the electrophysiology devices market is the introduction of leadless pacemakers. Leadless pacemakers serve as viable alternatives to the conventional variants, especially in case of patients who have a history of device infections. Traditional pacemakers are emerging as a major area of concern, as they are associated with a substantial risk of morbidity. This is laying a strong foundation for a faster adoption of leadless pacemakers.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2277
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
The growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and R&D activities to hamper the market growth
The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.
Top Companies Profiled in the Report:
Abbott Laboratories (U.S.), Bio sense Webster, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), GE Healthcare
Electrophysiology Devices Market Segmentation:
Product (Revenue in Million USD; 2018–2028)
- EP Ablation Catheters
- Cryoablation EP Catheters
- Radiofrequency Ablation Catheters
- Irrigated-tip Radiofrequency Ablation Catheters
- Conventional Radiofrequency Ablation Catheters
- Microwave Ablation Systems
- Laser Ablation Systems
- Navigational Advanced Mapping Accessories
- EP Laboratory Devices
- EP X-Ray Systems
- 3D Mapping Systems
- EP Recording Systems
- EP Remote Steering Systems
- Others
- EP Diagnostic Catheters
- Conventional EP Diagnostic Catheters
- Steerable Diagnostic Catheters
- Fixed Diagnostic Catheters
- Advanced EP Diagnostic Catheters
- Ultrasound EP Diagnostic Catheters
- Conventional EP Diagnostic Catheters
- Access Devices
- Others
Indication (Revenue in Million USD; 2018–2028)
- Atrial Fibrillation (AF)
- Atrial Flutter
- Wolff-Parkinson-White Syndrome (WPW)
- Atrioventricular Nodal Reentry Tachycardia (AVNRT)
- Right Atrial Tachycardia
- Right Atrial Flutter
- Left Atrial Flutter
- Right Ventricular Tachycardia
- Left Ventricular Tachycardia
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Electrophysiology Devices market over the forecast period?
- What are the major factors driving the growth of the Global Electrophysiology Devices Market?
- What are the key challenges impacting the global Electrophysiology Devices market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Request customization on the report @ https://www.reportsanddata.com/request-customization-form/2277
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Explore Latest Trending Research Reports By Reports and Data:
Glycogen Storage Disease Market @ https://www.biospace.com/article/rising-patient-awareness-of-rare-disorders-and-better-healthcare-are-expected-to-drive-glycogen-storage-disease-market-growth-over-the-forecast-period-of-2030/
Axial Spondylarthritis Market @ https://www.biospace.com/article/rising-numbers-of-research-and-development-activities-of-pharmaceuticals-for-the-symptomatic-treatment-is-expected-to-drive-axial-spondylarthritis-market-revenue-growth-by-2030/
Real Time Polymerase Chain Reaction (qPCR) Market @ https://www.biospace.com/article/real-time-polymerase-chain-reaction-qpcr-market-witness-astonishing-growth-by-forecast-2022-2030-reports-and-data/
Personalized Therapy Biosimulation Market @ https://www.biospace.com/article/personalized-therapy-biosimulation-market-size-worth-usd-3-164-1-million-in-2028-emergen-research/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos